HRP20160389T1 - Derivati orvinola i tevinola korisni u liječenju bolesti ovisnosti o drogama i alkoholu - Google Patents
Derivati orvinola i tevinola korisni u liječenju bolesti ovisnosti o drogama i alkoholu Download PDFInfo
- Publication number
- HRP20160389T1 HRP20160389T1 HRP20160389TT HRP20160389T HRP20160389T1 HR P20160389 T1 HRP20160389 T1 HR P20160389T1 HR P20160389T T HRP20160389T T HR P20160389TT HR P20160389 T HRP20160389 T HR P20160389T HR P20160389 T1 HRP20160389 T1 HR P20160389T1
- Authority
- HR
- Croatia
- Prior art keywords
- compound
- pharmaceutically acceptable
- solvate
- compound according
- acceptable salt
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
- C07D489/09—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems
- C07D489/10—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems with a bridge between positions 6 and 14
- C07D489/12—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems with a bridge between positions 6 and 14 the bridge containing only two carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4748—Quinolines; Isoquinolines forming part of bridged ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
- C07D489/09—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems
- C07D489/10—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems with a bridge between positions 6 and 14
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/08—Bridged systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Addiction (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Emergency Medicine (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1111775.1A GB201111775D0 (en) | 2011-07-08 | 2011-07-08 | Compounds and uses thereof |
| EP12735607.9A EP2729469B1 (en) | 2011-07-08 | 2012-07-05 | Orvinol and thevinol derivatives useful in the treatment of drug and alcohol abuse |
| PCT/GB2012/051575 WO2013007986A1 (en) | 2011-07-08 | 2012-07-05 | Orvinol and thevinol derivatives useful in the treatment of drug and alcohol abuse |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20160389T1 true HRP20160389T1 (hr) | 2016-07-01 |
Family
ID=44544490
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HRP20160389TT HRP20160389T1 (hr) | 2011-07-08 | 2012-07-05 | Derivati orvinola i tevinola korisni u liječenju bolesti ovisnosti o drogama i alkoholu |
Country Status (15)
| Country | Link |
|---|---|
| US (5) | US9051334B2 (enExample) |
| EP (1) | EP2729469B1 (enExample) |
| JP (2) | JP6117780B2 (enExample) |
| CA (1) | CA2841169C (enExample) |
| CY (1) | CY1117674T1 (enExample) |
| DK (1) | DK2729469T3 (enExample) |
| ES (1) | ES2572508T3 (enExample) |
| GB (1) | GB201111775D0 (enExample) |
| HR (1) | HRP20160389T1 (enExample) |
| HU (1) | HUE028785T2 (enExample) |
| PL (1) | PL2729469T3 (enExample) |
| RS (1) | RS54830B1 (enExample) |
| SI (1) | SI2729469T1 (enExample) |
| SM (1) | SMT201600154B (enExample) |
| WO (1) | WO2013007986A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201111775D0 (en) | 2011-07-08 | 2011-08-24 | Univ Bath | Compounds and uses thereof |
| WO2013050748A2 (en) | 2011-10-03 | 2013-04-11 | Johnson Matthey Plc | An improved method of preparing buprenorphine |
| EP3087078B1 (en) * | 2013-12-26 | 2019-05-15 | Purdue Pharma LP | 7-beta-alkyl analogs of orvinols |
| TW201607923A (zh) | 2014-07-15 | 2016-03-01 | 歌林達有限公司 | 被取代之氮螺環（４．５）癸烷衍生物 |
| GB201716830D0 (en) | 2017-10-13 | 2017-11-29 | Cambrex Charles City Inc | New Process |
| CN110117288A (zh) * | 2018-02-07 | 2019-08-13 | 复旦大学 | 7β-甲基-奈培酮衍生物及其制备方法和用途 |
| CN114195798B (zh) * | 2021-12-31 | 2023-07-28 | 复旦大学 | 7α-甲基稠环吗啡类衍生物及其制备方法和用途 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1136214A (en) | 1965-06-15 | 1968-12-11 | Reckitt & Sons Ltd | Thebaine and oripavine derivatives |
| GB937214A (en) | 1961-06-02 | 1963-09-18 | J F Macfarlan & Company Ltd | Oripavine derivatives |
| US3474101A (en) | 1960-09-05 | 1969-10-21 | Reckitt & Sons Ltd | Thebaine and oripavine derivatives |
| GB925723A (en) | 1960-09-05 | 1963-05-08 | J F Macfarlan & Company Ltd | Novel thebaine derivatives |
| GB902659A (en) | 1961-02-02 | 1962-08-09 | J F Macfarlan & Company Ltd | A process for the production of a derivative of thebaine |
| NL289751A (enExample) | 1962-03-02 | |||
| DE1493696A1 (de) | 1965-02-17 | 1969-12-18 | Hoechst Ag | Verfahren zur Herstellung klarfluessiger,leicht mit Wasser verduennbarer Fettsaeurekondensationsprodukte |
| WO2004078178A1 (en) | 2003-03-03 | 2004-09-16 | Markus Heilig | Buprenorphine compounds for treatment of alcohol dependence and excessive alcohol use |
| GB201111775D0 (en) * | 2011-07-08 | 2011-08-24 | Univ Bath | Compounds and uses thereof |
| JP6314571B2 (ja) * | 2013-12-16 | 2018-04-25 | ヤマハ株式会社 | 反力発生装置 |
-
2011
- 2011-07-08 GB GBGB1111775.1A patent/GB201111775D0/en not_active Ceased
-
2012
- 2012-07-05 CA CA2841169A patent/CA2841169C/en active Active
- 2012-07-05 ES ES12735607T patent/ES2572508T3/es active Active
- 2012-07-05 DK DK12735607.9T patent/DK2729469T3/en active
- 2012-07-05 HR HRP20160389TT patent/HRP20160389T1/hr unknown
- 2012-07-05 EP EP12735607.9A patent/EP2729469B1/en active Active
- 2012-07-05 RS RS20160426A patent/RS54830B1/sr unknown
- 2012-07-05 HU HUE12735607A patent/HUE028785T2/en unknown
- 2012-07-05 SI SI201230514A patent/SI2729469T1/sl unknown
- 2012-07-05 WO PCT/GB2012/051575 patent/WO2013007986A1/en not_active Ceased
- 2012-07-05 PL PL12735607.9T patent/PL2729469T3/pl unknown
- 2012-07-05 JP JP2014519623A patent/JP6117780B2/ja active Active
- 2012-07-05 US US14/131,361 patent/US9051334B2/en active Active
-
2015
- 2015-03-31 US US14/674,578 patent/US9259422B2/en active Active
- 2015-07-06 JP JP2015135460A patent/JP6117862B2/ja active Active
-
2016
- 2016-01-20 US US15/001,553 patent/US9480684B2/en active Active
- 2016-05-31 SM SM201600154T patent/SMT201600154B/it unknown
- 2016-06-21 CY CY20161100558T patent/CY1117674T1/el unknown
- 2016-10-27 US US15/336,193 patent/US9890170B2/en active Active
-
2017
- 2017-10-03 US US15/723,871 patent/US10030031B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US20170044173A1 (en) | 2017-02-16 |
| EP2729469B1 (en) | 2016-03-30 |
| DK2729469T3 (en) | 2016-07-18 |
| RS54830B1 (sr) | 2016-10-31 |
| SMT201600154B (it) | 2016-08-31 |
| CA2841169A1 (en) | 2013-01-17 |
| ES2572508T3 (es) | 2016-05-31 |
| US10030031B2 (en) | 2018-07-24 |
| CA2841169C (en) | 2019-08-27 |
| US9259422B2 (en) | 2016-02-16 |
| US9480684B2 (en) | 2016-11-01 |
| JP2015172089A (ja) | 2015-10-01 |
| US20140213603A1 (en) | 2014-07-31 |
| WO2013007986A1 (en) | 2013-01-17 |
| SI2729469T1 (sl) | 2016-07-29 |
| JP6117862B2 (ja) | 2017-04-19 |
| HUE028785T2 (en) | 2017-01-30 |
| US9051334B2 (en) | 2015-06-09 |
| US20150202200A1 (en) | 2015-07-23 |
| CY1117674T1 (el) | 2017-05-17 |
| US9890170B2 (en) | 2018-02-13 |
| EP2729469A1 (en) | 2014-05-14 |
| PL2729469T3 (pl) | 2016-09-30 |
| US20160136151A1 (en) | 2016-05-19 |
| JP6117780B2 (ja) | 2017-04-19 |
| GB201111775D0 (en) | 2011-08-24 |
| HK1198031A1 (zh) | 2015-03-06 |
| US20180030062A1 (en) | 2018-02-01 |
| JP2014522854A (ja) | 2014-09-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO6321289A2 (es) | Compuestos de ester boronato y composiciones farmaceuticas de los mismos | |
| JP2012511588A5 (enExample) | ||
| HRP20180483T1 (hr) | Spoj kinolona | |
| HRP20160030T1 (hr) | Derivati 6,7-dihidro-pirazolo[1,5-a]pirazin-4-ilamina koji su korisni kao inhibitori beta-sekretaze (bace) | |
| HRP20150543T1 (hr) | Međuprodukti za pripravu halikondrina b | |
| HRP20230162T1 (hr) | Heteroarilni inhibitori enzima pde4 | |
| TNSN07164A1 (en) | Quinuclidine derivatives and their use as muscarinic m3 receptor antagonists | |
| JP2013510124A5 (enExample) | ||
| HRP20171340T1 (hr) | Postupak za pripremu treprostinila i njegovih derivata | |
| HRP20130202T1 (hr) | Spojevi imidazo[1,2-a] pirazina za lijeäśenje virusnih infekcija kao što je hepatitis | |
| BRPI1009333B8 (pt) | compostos inibidores de beta-secretase, seus usos, bem como composição farmacêutica | |
| AR067757A1 (es) | Derivados de imidazo[4,5-c]piridin-2-ona, composiciones farmaceuticas que los contienen, procedimiento para su preparacion y uso de los mismos como agentes antivirales. | |
| AR064389A1 (es) | Derivados heterociclicos de nicotinamida utiles en el tratamiento de afecciones y enfermedades alergicas y respiratorias, y composiciones farmaceuticas que los contienen. | |
| RU2014123434A (ru) | Фармацевтические соединения | |
| RU2016110096A (ru) | Новое хинолин-замещенное соединение | |
| AR069509A1 (es) | Pirido (3,2-e) pirazinas, su procedimiento de preparacion y uso como inhibidores de fosfodiesterasa 10 | |
| HRP20160641T1 (hr) | Fuzionirani triciklički spojevi kao inhibitori raf kinaze | |
| RU2017123114A (ru) | 3-оксо-3-(ариламино)пропионаты, способ их получения и их применение в получении пирролидинонов | |
| JP2016505536A5 (enExample) | ||
| HRP20140501T1 (hr) | Derivati benzazepina korisni kao antagonisti vazopresina | |
| RU2015117251A (ru) | Новые соединения | |
| DE602007009839D1 (de) | Imidazo ä1,2-aüpyridin-2-carboxamid-derivate, herstellungsverfahren und ihre verwendung für therapeutika | |
| AR086100A1 (es) | Compuestos de cromenona y composiciones farmaceuticas que los contienen | |
| MX383762B (es) | Derivados de glutarimida, uso de los mismos, composición farmacéutica basada en los mismos y métodos para producir derivados de glutarimida. | |
| JP2012519653A5 (enExample) |